期刊文献+

凝血变化在SLE患者肾损害中的意义 被引量:1

Coagulative index changes in kidney damage in patients with SLE
下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者肾损害时凝血指标的变化及意义。方法选取54例SLE患者为观察组,其中分为肾损害组29例,非肾损害组25例;检测血浆D-二聚体(D-Dimer,D-D)、纤维蛋白原降解产物(FDP)、血管性假性血友病因子抗原(VWF:Ag)、凝血酶调节蛋白(TM)、组织型纤溶酶激活物(t-PA)、纤维蛋白原(FIB)和血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)的水平,并作对比分析。结果 SLE组D-D、VWF:Ag、TM和t-PA明显高于对照组(P<0.01);肾损害组上述四项指标明显高于非肾损害组(P<0.01);与对照组比较,PT、APTT明显缩短(P<0.01);TT和FIB两项指标无统计学意义(P>0.05)。结论 D-D、VWF:Ag、TM、FDP和t-PA的水平变化与系统性红斑狼疮患者的肾损害明显关联,指标水平随着肾损害的加重而升高。 Objective To investigate the changes and significance of coagulative indexs of kidney damage in patients with systemic lupus erythematosus (SLE). Methods A total of 54 patients with SLE in the observation group, the group of 29 cases of kidney damage, kidney damage group of 25 patients; plasma D-dimer (D-Dimer, D-D), fibrinogen degra- dation product (FDP), vascularvon Willebrand factor antigen (VWF: Ag), thrombomodulin (TM), tissue-type plasminogen activator (t-PA), fibrinogen (FIB), and the levels of prothrombin time (PT), activated partial thromboplastin time (APTr) and thrombin time 0T) were detected and compared. Results SLE group DD, VWF: Ag, TM and t-PA were significantly higher (P 〈 0.01); these four indicators of kidney damage group was also significantly higher than that of non-renal impairment group (P 〈 0.01); Fq', APTY was significantly shorter (in comparison with the control group (P 〈 0.01); however, for Tr and FIB, there were no significant differences between the two groups (P 〉 0.05). Conclusion D-D, VWF: Ag, TM, FDP and t-PA levels in patients with SLE kidney were significantly associated with kidney damage. Further more, levels of these indicators were increased along with the severity of kidney damage.
作者 梁艳梅 寇洁
出处 《中国现代医生》 2013年第2期83-84,共2页 China Modern Doctor
关键词 系统性红斑狼疮 凝血指标 肾损害 Systemic lupus erythematosus (SLE) Coagulative index Kidney damage
  • 相关文献

参考文献9

二级参考文献25

  • 1姜学义,峰下哲,韩春雷,杨学莉,汪整辉,寇丽筠,王黎曼,杨杰.系统性红斑狼疮患者纤溶功能测定[J].中华皮肤科杂志,1995,28(4):207-209. 被引量:5
  • 2郝素珍.狼疮抗凝因素的研究进展[J].国外医学(免疫学分册),1995,18(2):77-80. 被引量:4
  • 3Guidelinea for referral and management of systemic Lupus erythematosus in adults.American collee of Rheumatology Ad HocCommittee on systemic Lupus Erythematousus Guidelines[J].Arthritis Rheum,1999,42(9):1785-1796.
  • 4Bombardier C,Gladman D D,Urowitz M B,et al.Derivation of the SLEDAI:a disease activity index for Lupus patients[J].Arthritis Rheum,1992,35(6):630-640.
  • 5Raziuddin S,Nur M A,Wabel A A.Incereased circulating HLADR+CD4+T cells insystemic Lupus erythematosus:altertions associated with prednisolone therapy[J].Scand J Immunol,1990,31(2):139-145.
  • 6Meada N,sekigawa I,Iida N,et al.Relationship between CD4+/CD8+T cell ratio and T cell activation in systemic Lupus erythematousus[J].Scand Rheumatd,1999,28(3):166.
  • 7Erkeller-Yuksel F M,Lydyard P M,Isenherg D A.Lack of NK cells in Lupus patients with renal involvmen[J].Lupus,1997,8 (6):708-712.
  • 8蒋明 朱立平 林孝义 主编.风湿病学[M].北京:科学出版社,1998.1031-1032.
  • 9JENKINS A J, LYONS T J, ZHENG D, et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephritis [J]. Kidney Int,2003,64(3) :817 - 828.
  • 10JOVEN J, SIMO J M, VILELLA E, et al. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome:relation to remission of proteinurial [J]. Clin Chem, 1995,41 (6 Pt 1 ) :908 - 913.

共引文献183

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部